Target intelligence / Profile preview

Multiple microbial cellular components

Molecular classification
Other
01

Overview

Multiple microbial cellular components refers to the diverse array of structural and functional molecules within microorganisms—including bacteria, viruses, and fungi—that serve as targets for broad-spectrum antimicrobial agents (StatPearls, 2023). Unlike targeted antibiotics that inhibit specific metabolic pathways, agents hitting multiple components typically exert rapid, non-specific effects such as the denaturation of proteins, disruption of lipid membranes, and oxidation of nucleic acids (Journal of Hospital Infection, 2004). This multi-target approach is the hallmark of antiseptics, disinfectants, and certain topical anti-infectives, making it difficult for microbes to develop resistance (CDC, 2008). These agents are critical in clinical practice for surgical site preparation, wound management, and environmental decontamination to prevent the spread of infectious diseases (NIH, 2022). Common examples of such agents include povidone-iodine, chlorhexidine, and various alcohols, which are used to reduce microbial load on skin and surfaces (PubChem, 2023). Because these mechanisms can also affect host cells, their application is primarily restricted to topical or external use to avoid systemic toxicity (StatPearls, 2023). The lack of specificity allows these agents to remain effective against a wide range of pathogens, including multi-drug resistant organisms.

Other names
Microbial cell structuresBacterial cellular componentsFungal cellular componentsViral componentsMicrobial macromolecules
02

Mechanism of action

Drugs targeting multiple microbial cellular components typically act through non-specific mechanisms such as protein denaturation, membrane disruption, and oxidative damage to nucleic acids and enzymes (StatPearls, 2023; Journal of Hospital Infection, 2004).

03

Biological functions

Microbial cell wall integrityMembrane permeabilityProtein foldingNucleic acid stabilityEnzymatic activity
04

Disease associations

InfectionSepsisSkin and soft tissue infection
05

Safety considerations

Tissue irritationCytotoxicity to human cells (e.g., fibroblasts)Delayed wound healingContact dermatitisSystemic toxicity upon significant absorption
06

Interacting drugs

Povidone-iodine

8 more in the full profile.

07

Biomarkers

Microbial colony forming units (CFU)Minimum inhibitory concentration (MIC)C-reactive protein (CRP)Procalcitonin

Beyond the preview

Go deeper on Multiple microbial cellular components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple microbial cellular components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call